‘Strongly performing’ derivatives provider has aspiration for index inclusion.
Analysts say it could cost the company between 5% to 10% of ebitda.
Analysts label unfavourable Medicare decision very material for diagnostics company.
China’s regulator re-registers Synlait Dunsandel plant for China infant formula exports.
Dairyworks and Talbot Forest Cheese on the block in order to pay down debt.
Company directors need to lead the charge on considering risks and rewards from generative AI revolution.
Management are cautiously optimistic sales will continue to improve, although Middle East still struggling.
The results reflect a challenging period for the kiwifruit industry.
A premium is being placed on profitability, for tech companies.
The NZX-listed healthcare provider wants to the Government to ‘significantly’ increase funding.